MedTrace Logo

Acceptability & Tolerance of Immediate Versus Delayed Postpartum Contraceptive Implant

NCT03353012 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-07-26

No results posted yet for this study

Summary

To study and compare acceptability and tolerance between breast-feeding post-partum woman, who receive contraceptive implant 48-72 hours after giving birth or at 5-7 weeks after giving birth, using either Levonorgestrel or Etonogestrel contraceptive implant.

Conditions

  • Breastfeeding
  • Post Partum

Interventions

DRUG

Etonogestrel Drug Implant

Etonogestrel 68 mg (single rod) is implanted at inner arm of participant.

DRUG

Levonorgestrel Drug Implant

Levonorgestrel 75 mg (2 rods) are implanted at inner arm of participant.

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Unnop Jaisamrarn, M.D. · Chulalongkorn University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-05-01
Completion
2018-08-01

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03353012 on ClinicalTrials.gov